journal article Open Access Feb 24, 2023

Examining the Utility of Rapid Salivary C-Reactive Protein as a Predictor for Neonatal Sepsis: An Analytical Cross-Sectional Pilot Study

Diagnostics Vol. 13 No. 5 pp. 867 · MDPI AG
View at Publisher Save 10.3390/diagnostics13050867
Abstract
This study aimed to compare the rapid bedside quantitative assessment of C-reactive protein (CRP) in saliva to serum CRP to predict blood culture-positive sepsis in neonates. The research was carried out over eight months at Fernandez Hospital in India (February 2021–September 2021). The study included 74 randomly selected neonates with clinical symptoms or risk factors of neonatal sepsis requiring blood culture evaluation. SpotSense rapid CRP test was conducted to estimate salivary CRP. In analysis, the area under the curve (AUC) on the receiver operating characteristics (ROC) curve was used. The study population’s mean gestational age and median birth weight were 34.1 weeks (SD: ±4.8) and 2370 g (IQR: 1067–3182). The AUC on ROC curve analysis for predicting culture-positive sepsis was 0.72 (95% CI: 0.58 to 0.86, p-value: 0.002) for serum CRP and 0.83 (95% CI: 0.70 to 0.97, p-value: <0.0001) for salivary CRP. The Pearson correlation coefficient between salivary and serum CRP was moderate (r = 0.352, p-value: 0.002). Salivary CRP cut-off scores were comparable to serum CRP in terms of sensitivity, specificity, PPV, NPV, and accuracy in predicting culture-positive sepsis. The rapid bedside assessment of salivary CRP appears to be an easy and promising non-invasive tool in culture-positive sepsis prediction.
Topics

No keywords indexed for this article. Browse by subject →

References
22
[2]
Causes of death in preterm neonates (<33 weeks) born in tertiary care hospitals in India: analysis of three large prospective multicentric cohorts

Kajal Jain, M. Jeeva Sankar, Sushma Nangia et al.

Journal of Perinatology 2019 10.1038/s41372-019-0471-1
[3]
Goldfarb "The global burden of pediatric and neonatal sepsis: A systematic review" Lancet Respir. Med. (2018) 10.1016/s2213-2600(18)30063-8
[4]
Neonatal sepsis

Andi L Shane, Pablo J Sánchez, Barbara J Stoll

The Lancet 2017 10.1016/s0140-6736(17)31002-4
[5]
(2021, October 10). Neonatal Infection: Antibiotics for Prevention and Treatment. NICE Guideline [NG195] Published: 20 April 2021. Available online: www.nice.org.uk.
[6]
Philip "Detection of neonatal sepsis of late onset" JAMA (1982) 10.1001/jama.1982.03320290035027
[7]
Hofer "An Update on the Use of C-Reactive Protein in Early-Onset Neonatal Sepsis: Current Insights and New Tasks" Neonatology (2012) 10.1159/000336629
[8]
Benitz "Adjunct Laboratory Tests in the Diagnosis of Early-Onset Neonatal Sepsis" Clin. Perinatol. (2010) 10.1016/j.clp.2009.12.001
[9]
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

Laura Evans, Andrew Rhodes, Waleed Alhazzani et al.

Intensive Care Medicine 2021 10.1007/s00134-021-06506-y
[10]
Qaraqei "Association between the timing of antibiotics admin-istration and outcome of neonatal sepsis" J. Infect. Public Health (2022) 10.1016/j.jiph.2022.05.004
[11]
Anne "A quality improvement initiative to improve management of procedural pain in preterm neonates" Pediatr. Anesthesia (2020) 10.1111/pan.14075
[12]
Lemyre "Fetus and Newborn Committee Minimizing blood loss and the need for transfusions in very premature infants" Paediatr. Child Health (2015) 10.1093/pch/20.8.451
[13]
Lin, G., Küng, E., Smajlhodzic, M., Domazet, S., Friedl, H., Angerer, J., Wisgrill, L., Berger, A., Bingle, L., and Peham, J. (2021). Directed Transport of CRP Across In Vitro Models of the Blood-Saliva Barrier Strengthens the Feasibility of Salivary CRP as Biomarker for Neonatal Sepsis. Pharmaceutics, 13. 10.3390/pharmaceutics13020256
[14]
Weitkamp "Diagnostic Use of C-Reactive Protein (CRP) in Assessment of Neonatal Sepsis" Neoreviews (2005) 10.1542/neo.6-11-e508
[15]
Iyengar "Detection and Potential Utility of C-Reactive Protein in Saliva of Neonates" Front. Pediatr. (2014) 10.3389/fped.2014.00131
[16]
Omran "Salivary C-reactive protein, mean platelet volume and neutrophil lym-phocyte ratio as diagnostic markers for neonatal sepsis" J. Pediatr. (2018) 10.1016/j.jped.2017.03.006
[17]
Datla "Diagnostic Reliability of Salivary C-Reactive Protein as an Alternative Noninvasive Biomarker of Neonatal Sepsis" Indian Pediatr. (2021) 10.1007/s13312-021-2284-5
[18]
Pay "Towards salivary C-reactive protein as a viable biomarker of systemic inflammation" Clin. Biochem. (2019) 10.1016/j.clinbiochem.2019.04.006
[19]
Galhardo "Inflammatory markers in saliva for diagnosis of sepsis of hospitalizes patients" Eur. J. Clin. Investig. (2020) 10.1111/eci.13219
[20]
Tosson "Evaluation of serum and salivary C-reactive protein for diagnosis of late-onset neonatal sepsis: A single center cross-sectional study" J. Pediatr. (2021) 10.1016/j.jped.2021.01.004
[21]
Omran "Salivary C-reactive protein and mean platelet volume in diagnosis of late-onset neonatal pneumonia" Clin. Respir. J. (2017) 10.1111/crj.12723
[22]
Barekatain "Investigation of salivary C-reactive protein and in-terleukin-18 for the diagnosis of neonatal sepsis" J. Res. Med.Sci. Off. J. Isfahan Univ. Med. Sci. (2021)